DR. KENNETH W. HARLOW

INTERIM CEO, TECHNICAL ADVISORY BOARD & BOARD MEMBER

Kenneth Harlow is an experienced protein chemist with more than 30 years’ experience in academics and life sciences.  Kenneth serves both as an AligND Interim Chief Executive Officer as well as a technical advisor with respect to adapting the company’s unique nanowire technology to both protein- and nucleic acid-based based diagnostic platforms.

Kenneth obtained his Ph.D. in biochemistry from the Univ. of Illinois in Urbana-Champaign and is a specialist in utilizing and exploiting biochemical, biophysical and bioanalytical techniques and knowledge in the development of complex systems employing proteins and nucleic acids for industrial, life science and diagnostic applications.  He has been a tenured professor at the University of Copenhagen and has been employed in the Scandinavian pharma, biopharma and biotech sectors for the past 25 years, in capacities at Senior Scientist, VP and C-management levels in both large and SME companies.  In addition to his scientific qualifications, his experience in high-tech SMEs both as an employee and as a founder/owner, has provided deep insight into the interplay between IPR, Business Development, market selection and targeting, and funding strategies.

Kenneth is currently CTO at Upfront Chromatography A/S in Copenhagen, Denmark